NAS:HOLX (USA) Also trade in: Austria Germany UK

Hologic Inc

$ 48.13 -1.72 (-3.45%)
Volume: 1,975,775 Avg Vol (1m): 1,791,860
Market Cap $: 12.87 Bil Enterprise Value $: 15.51 Bil
P/E (TTM): 0.00 P/B: 6.33
Earnings Power Value 12.55
Net Current Asset Value -9.32
Tangible Book -7.34
Projected FCF 23.44
Median P/S Value 35.93
Graham Number 0
Peter Lynch Value 0.75
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 5/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.14
Cash-To-Debt range over the past 10 years
Min: 0.04, Med: 1.52, Max: 10000
Current: 0.14
0.04
10000
Equity-to-Asset 0.34
Equity-to-Asset range over the past 10 years
Min: 0.02, Med: 0.67, Max: 0.88
Current: 0.34
0.02
0.88
Debt-to-Equity 1.39
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.32, Max: 10
Current: 1.39
0
10
Debt-to-EBITDA 5.64
Debt-to-EBITDA range over the past 10 years
Min: -12.14, Med: 3.59, Max: 15.81
Current: 5.64
-12.14
15.81
Interest Coverage 1.00
Interest Coverage range over the past 10 years
Min: 1, Med: 2.38, Max: 3.6
Current: 1
1
3.6
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.90
DISTRESS
GREY
SAFE
Beneish M-Score -2.72
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 1.28%
WACC 6.04%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 4.21
Operating Margin range over the past 10 years
Min: 4.21, Med: 15.81, Max: 19.8
Current: 4.21
4.21
19.8
Net Margin % -0.89
Net Margin range over the past 10 years
Min: -135.4, Med: -1.39, Max: 24.7
Current: -0.89
-135.4
24.7
ROE % -1.27
ROE range over the past 10 years
Min: -60.17, Med: -0.73, Max: 30.67
Current: -1.27
-60.17
30.67
ROA % -0.43
ROA range over the past 10 years
Min: -32.08, Med: -0.35, Max: 9.88
Current: -0.43
-32.08
9.88
ROC (Joel Greenblatt) % 9.46
ROC (Joel Greenblatt) range over the past 10 years
Min: -369.68, Med: 25.23, Max: 208.04
Current: 9.46
-369.68
208.04
3-Year Total Revenue Growth Rate 6.00
3-Year Revenue Growth Rate range over the past 10 years
Min: -14.1, Med: 8.8, Max: 41.9
Current: 7.8
-14.1
41.9
3-Year Total EBITDA Growth Rate -37.80
N/A

Ratios

Current vs industry vs history
Forward PE Ratio 18.15
N/A
Price-to-Owner-Earnings 1300.81
Price-to-Owner-Earnings range over the past 10 years
Min: 8.31, Med: 23.29, Max: 1363.51
Current: 1300.81
8.31
1363.51
PB Ratio 6.33
PB Ratio range over the past 10 years
Min: 0.59, Med: 3.09, Max: 6.63
Current: 6.33
0.59
6.63
PS Ratio 3.94
PS Ratio range over the past 10 years
Min: 1.47, Med: 2.94, Max: 4.6
Current: 3.94
1.47
4.6
Price-to-Free-Cash-Flow 25.13
Price-to-Free-Cash-Flow range over the past 10 years
Min: 6.52, Med: 14.84, Max: 26.34
Current: 25.13
6.52
26.34
Price-to-Operating-Cash-Flow 20.59
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 5.51, Med: 13.09, Max: 928.86
Current: 20.59
5.51
928.86
EV-to-EBIT 202.78
EV-to-EBIT range over the past 10 years
Min: -58.7, Med: 24.5, Max: 235.6
Current: 202.78
-58.7
235.6
EV-to-EBITDA 28.45
EV-to-EBITDA range over the past 10 years
Min: -32.4, Med: 13.1, Max: 73.9
Current: 28.45
-32.4
73.9
EV-to-Revenue 4.68
EV-to-Revenue range over the past 10 years
Min: 2.6, Med: 4.2, Max: 5.8
Current: 4.68
2.6
5.8
Current Ratio 1.57
Current Ratio range over the past 10 years
Min: 0.79, Med: 2.74, Max: 7.31
Current: 1.57
0.79
7.31
Quick Ratio 1.11
Quick Ratio range over the past 10 years
Min: 0.61, Med: 2.15, Max: 6.57
Current: 1.11
0.61
6.57
Days Inventory 77.14
Days Inventory range over the past 10 years
Min: 72.07, Med: 86.95, Max: 108.2
Current: 77.14
72.07
108.2
Days Sales Outstanding 64.61
Days Sales Outstanding range over the past 10 years
Min: 56.15, Med: 60.73, Max: 74.61
Current: 64.61
56.15
74.61
Days Payable 29.88
Days Payable range over the past 10 years
Min: 21.81, Med: 29.16, Max: 46.12
Current: 29.88
21.81
46.12

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate 1.00
3-Year Share Buyback Rate range over the past 10 years
Min: -43.2, Med: -5, Max: 1
Current: 1
-43.2
1

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 2.05
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.45, Med: 1.75, Max: 13.86
Current: 2.05
0.45
13.86
Price-to-Median-PS-Value 1.34
Price-to-Median-PS-Value range over the past 10 years
Min: 0.15, Med: 0.85, Max: 2.57
Current: 1.34
0.15
2.57
Earnings Yield (Joel Greenblatt) % 0.49
Earnings Yield (Greenblatt) range over the past 10 years
Min: -49.1, Med: 2.4, Max: 10.6
Current: 0.49
-49.1
10.6
Forward Rate of Return (Yacktman) % 21.23
Forward Rate of Return range over the past 10 years
Min: 4.8, Med: 6.8, Max: 25.4
Current: 21.23
4.8
25.4

» HOLX's 30-Y Financials

Financials (Next Earnings Date: 2019-11-07)

» Interactive Chart

Peter Lynch Chart

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:HOLX

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Equipment    NAICS : 334517    SIC : 3844
Compare NYSE:STE XSWX:STMN NAS:XRAY XSWX:SOON NYSE:WST XTER:AFX TSE:7733 NYSE:COO NYSE:VAR NYSE:TFX NAS:NVCR NAS:MASI OCSE:DEMANT NYSE:HRC NYSE:RMD NYSE:HAE TSE:7747 MIL:AMP NZSE:FPH OSTO:EKTA B
Traded in other countries HO1.Germany 0J5Q.UK
Address 250 Campus Drive, Marlborough, MA, USA, 01752
Hologic Inc manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (47% of sales), breast health (37%), surgical (12%), and skeletal health (4%). While the company traditionally focused on breast health, the recent acquisition of Gen-Probe puts a much greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (74%), followed by Europe (12%) and Asia (8%). Hologic is headquartered in Bedford, Massachusetts.

More Statistics

Revenue (TTM) (Mil) $ 3,314.9
EPS (TTM) $ -0.12
Beta 0.93
Volatility % 25.19
52-Week Range $ 37.47 - 52.19
Shares Outstanding (Mil) 267.31

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA N
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy Y
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y